Steven Bogen MD PhD (President)
Dr. Bogen is a Board-certified Clinical Pathologist, having graduated from the University of Chicago Pritzker School of Medicine (M.D.) and the Weizman Institute of Science (Ph.D.), with a post-graduate residency and research fellowship at the Brigham and Women’s Hospital. He is Adjunct Professor of Pathology and Laboratory Medicine at Boston University School of Medicine and Medical Director, Clinical Chemistry Laboratory (part-time) at Tufts Medical Center. Dr. Bogen is an inventor on 22 patents, all of which relate to various medical diagnostic technologies. In addition, he served for a decade on several NIH grant review committees, mainly for the Innovative Molecular Analysis of Cancer Technologies program sponsored by the National Cancer Institute. Dr. Bogen was previously the founder of CytoLogix Corporation, which developed the Artisan® instrument system for automated complex histopathology stains (now sold and supported by Dako Corporation).
Seshi Sompuram PhD (Vice President, Research & Development)
Dr. Sompuram is Co-founder and VP R&D of Medical Discovery Partners LLC. He is also an Adjunct Assistant Professor of Pathology and Laboratory Medicine at Boston University School of Medicine. He received his PhD and trained as a Post-Doctoral Fellow at Boston University School of Medicine (Pathology/Immunology). Previously, he was Research Manager at Cytologix Corp., Cambridge MA. Dr. Sompuram is an inventor on 5 patents and co-authored numerous publications and textbooks. He has almost three decades of expertise in molecular biology, antibody engineering, and phage-display technologies (both antibody and peptide phage display). Dr. Sompuram has led the team’s efforts in applying these technologies in the area of cancer detection and diagnosis.
Kodela Vani MS (Manager, Manufacturing & Production)
Ms. Vani has over 20 years of laboratory experience in biochemistry and molecular biology and has operational responsibility for MDP’s cGMP manufacturing processes. After receiving a Masters degree in Chemistry, she initially worked in Drosophila genetics at Columbia University, NY and later in R&D at CytoLogix Corp., Cambridge MA. She has a broad range of research laboratory expertise, covering molecular biology, immunology, and pathology, and is a co-author on numerous peer-reviewed journal articles.
Anuradha Balasubramanian PhD (Quality Systems)
Dr. Balasubramanian has over 17 years of experience in preclinical toxicology, regenerative therapeutics, and developmental biology. Serving as a Quality and Compliance consultant, she oversees the in vitro medical device product development, QSR documentation, and compliance of the MDP product lines with cGMP regulations. Most recently, she is a consultant involved in CMC regulatory operations for drugs and biologics. Previously as a Scientist/Pediatric fellow in Boston Children’s Hospital/Harvard Medical School, she has held positions of increasing responsibility in research and laboratory management. She had also served as a post-doctoral fellow in Beth Israel Deaconess Medical Center/Harvard Medical School. Anuradha received her M.S. and Ph.D in Biochemistry from the University of Madras in India.
Ron Zeheb PhD (Scientific/Managerial Consultant)
Dr. Zeheb brings to MDP LLC a 25-year track record of successfully developing and launching medical diagnostic products. He received his PhD in biochemistry from the Albert Einstein College of Medicine of Yeshiva University. At Oncogene Science, Inc., he initiated and developed a new product line of quantitative immunoassays resulting in the commercialization of the company’s first ELISA kits. As Director of R&D for Ventana Medical Systems, he led the team that developed the first instrument for automating in situ hybridization assays. He was the founding Vice President of Research at CytoLogix Corporation, where he directed the development of the Artisan® staining platform and associated staining kits for both immunohistochemical and special stains applications. Dr. Zeheb was Senior Vice President of Research and Development at Dako Corporation (US) and the Director of Molecular and Immunohistochemical Laboratories in the Department of Anatomic Pathology of the Lahey Clinic. He has authored numerous publications and patents, and been the recipient of NIH and private research grants.
Gail Radcliffe PhD (Consultant in Regulatory Affairs)
Dr. Radcliffe (Radcliffe Consulting, Inc.) has more than 20 years experience assisting medical device and diagnostics companies with technical assessment, marketing and clinical/regulatory issues. Gail was awarded her Ph.D. in Molecular Biology from Brown University and completed a post-doctoral fellowship in molecular immunology at the University of Massachusetts Medical School. Afterwards, she worked at GENE-TRAK and then Cytyc, until 1998, when she founded Radcliffe Consulting Inc. Dr. Radcliffe consults with medical device companies, for market research, regulatory strategy (IVD vs. CLIA lab) and submissions, quality systems development and clinical trial support. Her experience includes a wide range of products in digital pathology, laser dissection devices, companion diagnostics, and multiplex molecular, POC and CLIA Waived in vitro diagnostic devices.
Brian Tracey PhD (Consultant in Image Analysis)
Brian Tracey received a Ph.D. from the Massachusetts Institute of Technology, Cambridge MA, in 1996. He worked in acoustical modeling and noise control at Cambridge Collaborative, Inc, at MIT Lincoln Laboratory in sonar signal processing, and at Neurometrix, Inc where he was a technical manager and developed algorithms for medical devices. In 2011 he joined the Tufts University Dept. of Electrical and Computer Engineering where he is a Professor of the Practice. At Tufts he teaches courses in digital signal processing and computing, and is active in research related to imaging and signal processing. In addition to working at Tufts, he maintains an active consulting practice.
Farzad Noubary PhD (Consultant in Statistical Analysis)
Dr. Noubary received a Ph.D. from Harvard University, Cambridge MA in Biostatistics. He is currently an Assistant Professor and Senior Statistician at Tufts University School of Medicine. Dr. Noubary’s research interests include statistical methods for the design and analysis of studies evaluating novel diagnostics, longitudinal data analysis, decision analysis, and clinical epidemiology, particularly in the context of HIV, TB, and other infectious diseases. He is also interested in innovative approaches to teaching biostatistics to clinical audiences and has experience developing a distance learning course. At Tufts, he is the primary instructor of the biostatistics curriculum in the Clinical and Translational Science Program at the Sackler School of Graduate Biomedical Sciences.